MiR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1

Journal of the American Society of Nephrology

Volumn 24, Issue 7, 2013, Pages 1073-1087

  Zhou, Hua ^a,b   Hasni, Sarfaraz A ^c   Perez, Paola ^a   Tandon, Mayank ^a   Jang, Shyh Ing ^a   Zheng, Changyu ^a   Kopp, Jeffery B ^c   Austin, Howard ^c   Balow, James E ^c   Alevizos, Ilias ^a   Illei, Gabor G ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 150; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SCORING SYSTEM;

EID: 84879902677     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012080849     Document Type: Article

References (45)

1. Nowling TK, Gilkeson GS: Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 13: 250, 2011
2. Fanouriakis A, Krasoudaki E, Tzanakakis M, Boumpas DT: Recent progress in the treatment of lupus nephritis. Mod Rheumatol 22: 803-813, 2012
3. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 25: 689-695, 1984
4. Lorenzen JM, Haller H, ThumT:MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7: 286-294, 2011
5. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K: Role of microRNAs in kidney homeostasis and disease. Kidney Int 81: 617-627, 2012
6. Patel V, Noureddine L: MicroRNAs and fibrosis. Curr Opin Nephrol Hypertens 21: 410-416, 2012
7. Farris AB, Colvin RB: Renal interstitial fibrosis: Mechanisms and evaluation. Curr Opin Nephrol Hypertens 21: 289-300, 2012
8. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGFbeta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437, 2007
9. WangQ, Wang Y,Minto AW, Wang J, ShiQ, Li X,Quigg RJ:MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22: 4126-4135, 2008
10. Putta S, Lanting L, Sun G, Lawson G, Kato M, Natarajan R: Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.JAm Soc Nephrol 23: 458-469, 2012
11. Chung AC, Huang XR, Meng X, Lan HY: miR-192 mediates TGF-beta/ Smad3-driven renal fibrosis. J AmSoc Nephrol 21: 1317-1325, 2010
12. Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-EdelsteinM, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, Cooper ME, Kantharidis P: Suppression of microRNA-29 expression by TGF-b1 promotes collagen expression and renal fibrosis. J AmSoc Nephrol 23: 252-265, 2012
13. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J: The miR-200 family regulates TGF-b1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 302: F369-F379, 2012
14. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC: Intrarenal expression of microRNAs in patientswith IgAnephropathy. Lab Invest 90: 98-103, 2010
15. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC: Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 23: 78-84, 2010
16. Dai Y, Sui W, Lan H, YanQ, Huang H, Huang Y: Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29: 749-754, 2009
17. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Wang G, Li PK, Szeto CC: Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 17: 346-351, 2012
18. Liu Q, Liu S, Shi Y, Li H, Hao J, Xing L, Cao Y, Duan H: Suppressors of cytokine signaling inhibit tubular epithelial cell-myofibroblast transdifferentiation. Am J Nephrol 34: 142-151, 2011
19. Shi Y, Zhang Y, Wang C, Du C, Zhao S, Qi Z, Zhang Q, Duan H: Suppressor of cytokine signaling-1 reduces high glucose-induced TGFbeta1 and fibronectin synthesis in human mesangial cells. FEBS Lett 582: 3484-3488, 2008
20. FujimotoM, Tsutsui H, XinshouO, TokumotoM,Watanabe D, Shima Y, Yoshimoto T, Hirakata H, Kawase I, Nakanishi K, Kishimoto T, Naka T: Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 16: 303-314, 2004
21. Alexakis C, Maxwell P, Bou-Gharios G: Organ-specific collagen expression: Implications for renal disease. Nephron, Exp Nephrol 102: e71-e75, 2006
22. Nakashima T, Yokoyama A,Onari Y, Shoda H, Haruta Y, Hattori N,Naka T, Kohno N: Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis. J Allergy Clin Immunol 121: 1269-1276, 2008
23. Ortiz-Muñoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, Sanz A, Blanco J, Mezzano S, Ortiz A, Egido J, Gomez-Guerrero C: Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 21: 763-772, 2010
24. Shankland SJ, Pippin JW, Reiser J, Mundel P: Podocytes in culture: Past, present, and future. Kidney Int 72: 26-36, 2007
25. Boor P, Ostendorf T, Floege J: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
26. García-Sánchez O, López-Hernández FJ, López-Novoa JM: An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int 77: 950-955, 2010
27. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, LandthalerM, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, PhanQ,ChienM,WeirDB, Choksi R,De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, PalkovitsM,Di Lauro R,Wernet P,Macino G, RoglerCE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, TamW, BrownsteinMJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414, 2007
28. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49: 461-469, 1996
29. Onetti Muda A, Feriozzi S, Rahimi S, Faraggiana T: Expression of TGFbeta receptors type I and II in human glomerulonephritis. Nephrol Dial Transplant 13: 279-284, 1998
30. Goumenos DS, Tsamandas AC, Oldroyd S, Sotsiou F, Tsakas S, Petropoulou C, Bonikos D, El Nahas AM, Vlachojannis JG: Transforming growth factor-beta(1) and myofibroblasts: A potential pathway towards renal scarring in human glomerular disease. Nephron 87: 240-248, 2001
31. Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, Mussolin L, Ruggero K, Bonanno L, Guffanti A, De Bellis G, Gerosa G, Stellin G, D'Agostino DM, Basso G, Bronte V, Indraccolo S, Amadori A, Zanovello P: Modulation of microRNA expression in human T-cell development: Targeting ofNOTCH3 bymiR-150. Blood 117: 7053-7062, 2011
32. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N, Sawada K: The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25: 1324-1334, 2011
33. Hedrich CM, Tsokos GC: Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 17: 714-724, 2011
34. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D: Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J AmSoc Nephrol 21: 438-447, 2010
35. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032, 2008
36. Shi Y, DuC, Zhang Y, Ren Y,Hao J, Zhao S, Yao F,DuanH: Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy. Am J Nephrol 31: 380-388, 2010
37. Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, Yoshimura A: SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J ExpMed 199: 1701-1707, 2004
38. Metcalf D, Mifsud S, Di Rago L, Nicola NA, Hilton DJ, Alexander WS: Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc Natl Acad Sci U S A 99: 943-948, 2002
39. ZeisbergM, Neilson EG:Mechanisms of tubulointerstitial fibrosis.J Am Soc Nephrol 21: 1819-1834, 2010
40. Saxena V, LieneschDW, Zhou M, Bommireddy R,AzharM,Doetschman T, Singh RR: Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 180: 1903-1912, 2008
41. Hammad AM, Youssef HM, El-Arman MM: Transforming growth factor beta 1 in children with systemic lupus erythematosus: A possible relation with clinical presentation of lupus nephritis. Lupus 15: 608-612, 2006
42. Jin T, Almehed K, Carlsten H, Forsblad-d'Elia H: Decreased serum levels of TGF-b1 are associated with renal damage in female patients with systemic lupus erythematosus. Lupus 21: 310-318, 2012
43. Xing Q, Su H, Cui J, Wang B: Role of Treg cells and TGF-b1 in patients with systemic lupus erythematosus:A possible relation with lupus nephritis. Immunol Invest 41: 15-27, 2012
44. MaoH, Li Z, Zhou Y, Li Z, Zhuang S, An X, Zhang B, Chen W, Nie J,Wang Z, Borkan SC, Wang Y, Yu X: HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 295: F202-F214, 2008
45. Sakairi T, Abe Y, Kopp JB: TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes. Nephrol Dial Transplant 26: 2746-2752, 2011